“…The proposed metabolites include: G6P (85,86) , xylulose 5-P (8) , the regulatory metabolite F2,6P 2 ( 43,87) , ketone bodies (88) and the product of the hexosamine pathway UDP-N-acetylglucosamine (79,80) which is the substrate for O-GlcNAc-modification of proteins. The induction of ChREBP target genes by high glucose is abolished by glucokinase inhibitors and markedly enhanced by inhibitors of G6P hydrolysis (42,32,53) . These inhibitors abolish and enhance, respectively, the elevation in PE pool in hepatocytes comprising G6P and downstream metabolites (42,32,53) .…”